Holen Sie sich die Stockscreener-App
7.1619
1.35%
0.1019
Schlusskurs vom Vortag:
$7.06
Offen:
$7.09
24-Stunden-Volumen:
106.65K
Relative Volume:
0.10
Marktkapitalisierung:
$626.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-5.4257
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+2.80%
1M Leistung:
+17.68%
6M Leistung:
+97.11%
1J Leistung:
-4.09%
1-Tages-Spanne:
$7.03
$7.18
1-Wochen-Bereich:
$6.78
$7.78
52-Wochen-Spanne:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
7.155 | 617.83M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
402.47 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.25 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.12 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
747.12 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.25 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
Risk vs reward if holding onto Terns Pharmaceuticals Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Terns Pharmaceuticals Inc. stock prediction for this weekEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
HC Wainwright & Co. Assumes Coverage on TERN with Neutral Rating | TERN Stock News - GuruFocus
Why is Terns Pharmaceuticals Inc. stock going down2025 Key Lessons & Long-Term Growth Portfolio Plans - khodrobank.com
Can trapped investors hope for a rebound in Terns Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - Newser
Terns Pharmaceuticals Inc. recovery potential after sell offWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Sentiment analysis tools applied to Terns Pharmaceuticals Inc.Weekly Trade Analysis & Fast Exit and Entry Strategy Plans - Newser
Terns Pharmaceuticals Inc. stock chart pattern explained2025 Analyst Calls & Weekly High Return Forecasts - Newser
Can Terns Pharmaceuticals Inc. maintain its current growth rate2025 Volatility Report & Capital Efficiency Focused Ideas - khodrobank.com
Earnings visualization tools for Terns Pharmaceuticals Inc.Exit Point & Fast Gaining Stock Strategy Reports - Newser
Terns Pharmaceuticals (TERN): Evaluating the High-Potential Clinical Pipeline and Strategic Path to Value Creation - AInvest
What is the long term forecast for Terns Pharmaceuticals Inc. stockWeekly Market Report & Entry Point Strategy Guides - khodrobank.com
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.Volume Spike & Free Risk Controlled Daily Trade Plans - Newser
What’s next for Terns Pharmaceuticals Inc. stockJuly 2025 Pullbacks & Smart Allocation Stock Reports - khodrobank.com
Historical volatility pattern of Terns Pharmaceuticals Inc. visualizedQuarterly Market Summary & Community Consensus Trade Alerts - Newser
Terns Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Using economic indicators to assess Terns Pharmaceuticals Inc. potentialMarket Movers & Accurate Buy Signal Notifications - Newser
Custom watchlist performance reports with Terns Pharmaceuticals Inc.Market Performance Recap & Real-Time Volume Trigger Notifications - Newser
Chart based analysis of Terns Pharmaceuticals Inc. trendsJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyWeekly Market Outlook & Weekly Market Pulse Updates - Newser
When is the best time to exit Terns Pharmaceuticals Inc.2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
Using R and stats models for Terns Pharmaceuticals Inc. forecastingEarnings Overview Report & Precise Trade Entry Recommendations - Newser
Analyzing net buyer seller activity in Terns Pharmaceuticals Inc.Quarterly Profit Summary & Smart Allocation Stock Reports - Newser
Can Terns Pharmaceuticals Inc. benefit from deglobalization2025 Bull vs Bear & Daily Stock Momentum Reports - khodrobank.com
Technical Charts Suggest Momentum Shift in Terns Pharmaceuticals Inc.Oil Prices & Stepwise Trade Signal Guides - beatles.ru
Is this a good reentry point in Terns Pharmaceuticals Inc.Jobs Report & Short-Term Swing Trade Alerts - Newser
Analyzing Terns Pharmaceuticals Inc. with risk reward ratio charts2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Big Money Moves: Is Terns Pharmaceuticals Inc. stock forming a cup and handleJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - khodrobank.com
What are Terns Pharmaceuticals Inc.’s technical support levelsJuly 2025 Movers & Fast Gaining Stock Strategy Reports - khodrobank.com
Momentum divergence signals in Terns Pharmaceuticals Inc. chartQuarterly Market Summary & Community Consensus Trade Alerts - Newser
Heatmap analysis for Terns Pharmaceuticals Inc. and competitorsWatch List & Trade Opportunity Analysis - Newser
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Terns Pharmaceuticals Inc-Aktie (TERN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gengos Andrew | Chief Financial Officer |
Jun 27 '25 |
Buy |
3.93 |
10,000 |
39,283 |
25,000 |
| Burroughs Amy L. | Chief Executive Officer |
Jun 25 '25 |
Buy |
3.87 |
23,314 |
90,230 |
47,083 |
| Gengos Andrew | Chief Financial Officer |
Jun 13 '25 |
Buy |
3.73 |
10,000 |
37,350 |
10,000 |
| Gengos Andrew | Chief Financial Officer |
Jun 16 '25 |
Buy |
3.95 |
5,000 |
19,732 |
15,000 |
| Kuriakose Emil | Chief Medical Officer |
Apr 01 '25 |
Sale |
2.49 |
952 |
2,366 |
53,317 |
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
| Vignola Mark J. | Chief Financial Officer |
Jan 02 '25 |
Sale |
5.72 |
8,129 |
46,524 |
83,811 |
0.23%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):